Good morning, everyone, and how are you today? We are doing just fine, thank you. Despite the gray skies hovering over the Pharmalot campus, our spirits remain sunny. And why not? Once again, we will trot out some advice from the Morning Mayor: Every brand new day should be unwrapped like a precious gift. While you stop to take that in, we will brew another cup of stimulation and prepare ourselves for another day of foraging for interesting items. On that note, here are some tidbits. Hope your day goes well and, of course, do keep in touch …

The Trump administration promises that more steps will be taken to tackle high drug costs, Axios writes. “In the weeks and months ahead, there is a lot of action — regulatory action that we are working on,” Health and Human Services Secretary Alex Azar says. “We still view ourselves as at the advanced stage of beginning at this effort” to lower drug prices, and that “everything is on the table if it helps deliver a solution. … There’s no one single step that solves all of those issues around drug pricing. We’re chipping away at them.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy